• Media Centre
  • Investor relations
  • Client area
  • Client area
  • Stewardship policy
  • Annual reports service

Form of Proxy

BIODEXA PHARMACEUTICALS PLC

Notes

No. Proposition For Against Abstain
1

TO RECEIVE THE COMPANYS REPORT AND ACCOUNTS FOR THE YEAR ENDED 31 DECEMBER 2025

2

TO APPROVE THE DIRECTORS REMUNERATION REPORT

3

TO RE-ELECT ANN MERCHANT AS A DIRECTOR OF THE COMPANY

4

TO RE-ELECT SIMON TURTON AS A DIRECTOR OF THE COMPANY

5

TO RE-ELECT SIJMEN DE VRIES AS A DIRECTOR OF THE COMPANY

6

TO ELECT FIONA POWELL (NEE SHARP) AS A DIRECTOR OF THE COMPANY

7

TO RE-APPOINT PKF LITTLEJOHN LLP AS AUDITOR OF THE COMPANY AND TO AUTHORISE THE DIRECTORS TO DETERMINE THE AUDITORS REMUNERATION

8

TO APPROVE THE PROPOSED SHARE CAPITAL REORGANISATION

9

TO AUTHORISE THE DIRECTORS TO ALLOT SHARES IN THE COMPANY

10

TO DISAPPLY STATUTORY PRE-EMPTION RIGHTS

11

TO APPROVE AND ADOPT NEW ARTICLES OF ASSOCIATION OF THE COMPANY